SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5

Published: 31 March 2022| Version 1 | DOI: 10.17632/sbmzjp6rj7.1
Contributor:
Spyridon Stavrou

Description

SARS-CoV-2 ORF7a, an accessory protein of SARS-CoV-2, blocks the antiviral effect of SERINC5. The data below are from a manuscript our lab has prepared for publications. The data below provides information on the RT-qPCR and luciferase experiments performed in this study.

Files

Categories

Virology, Host Defense, Severe Acute Respiratory Syndrome Coronavirus 2

Licence